This application claims priority under 35 U.S.C. §119 to Japanese Patent Application No. 2012-044546 filed on Feb. 29, 2012, the entire content of which is hereby incorporated by reference.
1. Field of the Invention
The present invention relates to a Co-based alloy for a living body and a stent using the same. More specifically, the present invention relates to a Co-based alloy for a living body that is suitable for being provided for the use in medical instruments such as instruments implanted into the living body and instruments contacting the living body, and relates to a stent using the alloy.
2. Background Art
A high degree of corrosion resistance and biocompatibility are required in alloys used for medical instruments implanted into the living body and medical instruments used by being brought into direct contact with the surface of the living body. In addition, for an alloy for a stent which is used for securing blood flow by dilating a portion where angiostenosis has been caused in the living body, a high degree of strength and elastic modulus are required. The alloys are also required to be highly visible in X-rays, that is, to have a high density, to have a high degree of blood compatibility, and the like.
As the Co-based alloy for a living body that satisfies the above requirements, an alloy (ASTM standards F90: hereinafter, abbreviated to an “ASTM F90 alloy”) containing Co-20Cr-15W-10Ni as main components, an alloy (see JP-A-2007-162121) composed of Co: 30% to 60%, Ni: 4% to 20%, Cr: 13% to 25%, C: 0.3% or less, Si: 2.0% or less, and Mn: 2.0% or less in terms of % by mass, and the like are known in the related art. Moreover, as the stent, a stent (see JP-T-2007-517536) which has a tubular body including an alloy obtained by adding at least one kind among Zr, Ta, and Mo to 20% or more of Ti, and specifies the yield strength, magnetic susceptibility, and mass-absorption coefficient of the alloy is known.
Among other biomaterials based on metals, the ASTM F90 alloy is particularly excellent in the above characteristics, and promising not only as an aortic stent, but also as a material for stents for microvessels such as a coronary stent and a stent for bile ducts in the future.
However, the ASTM F90 alloy and the alloy disclosed in JP-A-2002-130808 contain a large amount of Ni, which causes a Ni allergy, so a material for a stent that is excellent in various characteristics described above without containing Ni is required. Ni is contained to secure plastic workability, and recognized as an additive element necessary for imparting characteristics of a high degree of plastic workability for tube working which is necessary for fabricating a stent.
Therefore, if the alloy composed as above is made into a Ni-free alloy, this leads to a problem that working characteristics such as plastic workability deteriorate remarkably.
In addition, when the stent is inserted into the body, the position of the stent needs to be checked under radioscopy, so a material having high X-ray visibility is desired. However, since the stent is inserted into blood vessels, and a tubular stent for intravascular insertion and the like is formed to be extremely thin, the alloy composition in the related art is not necessarily sufficient in terms of X-ray visibility under the current circumstances, so higher X-ray visibility is required.
The present invention has been made to solve the above problems, and an object thereof is to provide a Ni-free Co-based alloy for a living body that has a high strength, a high elastic modulus, and excellent plastic workability. Another object of the present invention is to provide a Co-based alloy for a living body that has excellent X-ray visibility. In addition, still another object of the present invention is to provide a stent using the alloy.
The present invention has the following constitution as means for solving the above problems.
The present invention is a Co-based alloy for a living body based on Co—Cr—W—Fe, including a composition of Cr: 5% by mass to 30% by mass, W: 5% by mass to 20% by mass, Fe: 1% by mass to 15% by mass, Co as the remainder, and unavoidable impurities.
The present invention is the Co-based alloy for a living body based on Co—Cr—W—Fe according to the above aspect, further including C: 0.01% by mass to 0.15% by mass.
The present invention is the Co-based alloy for a living body based on Co—Cr—W—Fe according to the above aspect, wherein when the content of W is 5% by mass to 10% by mass, the content of Fe is 1% by mass to 5% by mass.
The present invention is the Co-based alloy for a living body based on Co—Cr—W—Fe according to the above aspect, wherein when the content of W is 11% by mass to 20% by mass, the content of Fe is 3% by mass to 15% by mass.
The present invention is a stent including the Co-based alloy for a living body according to any one of the above aspects.
For the Co-based alloy for a living body of the present invention, to an alloy based on Co—Cr—W, Fe which exhibits biocompatibility and has an effect of increasing a stacking fault energy of the alloy is added. In this manner, it is possible to prevent the formation of a strain-induced martensite ε-phase in a working step by stabilizing a γ-phase of the alloy, and to improve the plastic workability. In addition, since the Co-based alloy for a living body of the present invention does not contain Ni, there is no concern that this alloy may cause a Ni allergy in the living body.
In addition, since the Co-based alloy for a living body of the present invention has a composition obtained by adding Fe to an alloy based on Co—Cr—W, not only the plastic workability of the Co-based alloy, but also the elastic modulus and tensile strength can be improved. Moreover, since the Co-based alloy for a living body of the present invention contains W which contributes to the X-ray visibility, the X-ray visibility can be improved, so the alloy is suitable for an alloy for a stent.
The stent of the present invention uses the Co-based alloy for a living body of the present invention. Therefore, the stent does not cause a Ni allergy and has an excellent elastic modulus and tensile strength. Moreover, by containing W, the stent can exhibit excellent X-ray visibility.
In order to develop a Ni-free Co-based alloy for a living body that has a high degree of strength (high tensile strength), elastic modulus, and ductility and excellent plastic workability, the present inventors conducted thorough research. As a result, the inventors found that by adding Fe, which exhibits biocompatibility and has an effect of increasing a stacking fault energy of an alloy based on Co—Cr—W, to the alloy based on Co—Cr—W, as alloy elements, the above problems can be solved.
Hereinafter, the materials science investigations that led to the present invention will be described.
First, aiming at making an ASTM F90 alloy, which is known as a material having excellent characteristics as an alloy for a living body, into a Ni-free alloy, the present inventors investigated the effect obtained by the addition of Ni to the alloy.
Ni in the Co-based alloy based on the above elements is a material added to improve plastic workability. That is, it is considered that this is because addition of Ni stabilizes the γ-phase of the fcc structure (face-centered cubic) of the Co-based alloy, and the ε-phase of the hcp structure that is a strain-induced martensite phase is not formed during the step of working, and accordingly, the alloy acquires sufficient cold workability. On the other hand, if the ASTM F90 alloy is made into a Ni-free alloy, the cold workability thereof markedly deteriorates. It is considered this is because the stability of the γ-phase deteriorates since Ni is not added, and the ε-phase is formed from the early stage of the working, so stress concentration is caused in the interface between the γ-phase and the ε-phase, whereby the alloy is broken from the interface as a starting point.
Therefore, the inventor considered that it is important to stabilize the γ-phase as the fcc structure having excellent plastic workability so as to make an alloy composition that does not form the strain-induced martensite c-phase as the hcp structure during the step of working, and focus on the Stacking Fault Energy (SFE) of alloys in which phase transformation from the γ-phase to the ε-phase occurs, thereby further conducting examination.
Olson and Cohen have proposed the method of thermodynamically calculating the SFE of alloys in which phase transformation from the fcc (face-centered cubic) structure to the hcp (hexagonal-closed packed) structure occurs (Metall. Trans. 7A (1976), 1897-1904). According to them, if the stacking fault is regarded as thin hcp crystals, the SFE is represented as the sum of a term of volumetric energy and a term of surface energy, as shown in the following Formula (1).
γS F E=2ρ (ΔGγ→ε+Estrain)+2σ (1)
Herein, ΔGγ→ε, Estrain, and σ respectively represent the change in Gibbs energy accompanied by γ→ε transformation, an elastic strain energy generated when the ε-phase is formed in the γ-phase, and an interfacial energy in the γ/ε boundary, and ρ is the atomic density per 1 mol of a {111}γ plane and can be calculated by the following Formula (2).
Herein, a represents a lattice constant of the fcc phase, and N represents the Avogadro constant. In the study on austenitic steel using Formula (1), volumetric change in the γ→ε transformation is small. Therefore, Estrain is negligible, and likewise, a term of elastic strain energy is negligible in the case of the Co alloy. In addition, the value of 2σ practically does not show temperature dependency, and is about 15 mJ/m2 in an fcc alloy. If the change in magnetic energy in ΔGγ→ε of cobalt is neglected, and only the change in chemical Gibbs energy is considered as the term of volumetric energy, it is possible to calculate the temperature dependency and the composition dependency of the SFE by using Thermo-Calc (manufactured by Thermo-Calc Software: ver. 4.1.3.41, database: FE ver. 6) as general purpose thermodynamics calculation software.
As shown in
In addition,
As shown in
On the other hand, in the respective alloys including the Co-20Cr-30Ni-10Mo alloy, the ASTM F90 alloy, the SUS304 steel, and the 800H high nickel steel, the stability of the γ-phase or the austenite phase of the fcc structure is high all the time in the temperature range shown in
Among these Co-based alloys, the ASTM F90 alloy having a large SFE value has an SFE that is almost equivalent to that of practically used alloys classified as low-SFE alloys other than the Co alloy, such as austenite stainless steel. In the ASTM F90 alloy, the γ-phase is stably present until the temperature reaches room temperature, and the phase transformation to the martensite ε-phase induced by working hardly occurs. Consequently, the ASTM F90 alloy is known to be an alloy having excellent plastic workability at room temperature. Accordingly, it could be confirmed that the Co-based alloy having a large SFE is excellent in plastic workability.
In addition, the Co—Ni—Cr—Mo-based alloy that is represented by a Co-20Cr-30Ni-10Mo alloy having an SFE of approximately intermediate magnitude is known to exhibit a high degree of elasticity and strength. However, it is known that this alloy is inferior to the ASTM F90 alloy in terms of plastic workability, and if a large amount of Ni is added thereto, working-induced martensitic transformation is inhibited, so plastic working such as cold rolling can be performed.
From the above results, it was understood that in the Co-based alloy, the higher the SFE is, the more the plastic workability is improved, so adding an element having an effect of improving SFE to the Co-based alloy is effective for improving the plastic workability of the alloy.
In any alloys, SFE tends to increase linearly with temperature, and the value (about 30 mJm−2) that is obtained by extrapolating the calculation result of the SUS304 steel to room temperature is close to the value reported in the related art. Moreover, Ericsson reported in the past the temperature dependency of SFE of Co- and Co—Ni-based alloys by the method using a Transmission Electron Microscope (TEM) (Acta Metall 14 (1966), 853-865), and the value is almost identical to that of the Co—Ni-based alloy obtained herein. Therefore, it is possible to judge that the SFE's and the temperature dependency in different alloys that are constructed using the same database are reliable.
In the Co-based alloy for a living body of the present invention, as alloy elements to be added to the Co—Cr—W-based alloy, alloy elements showing biocompatibility and having an effect of increasing the stacking fault energy of the alloy are preferable. Among these, it is preferable to add Fe. By adding Fe, it is possible to increase the SFE of the Co-based alloy for a living body and to improve the plastic workability, the strength, the elastic modulus, and the like. The technique of specifying such alloy elements will be described below.
From the Formula (1), the size of a rough estimate of SFE of an alloy can be found by estimating ΔGγ→ε which represents the change in Gibbs energy accompanied by γ→ε transformation, that is, by estimating the difference between the free energy of the γ-phase and the free energy of the ε-phase. The larger the ΔGγ→ε, the greater the SFE. Accordingly, it is considered that when various elements are added to Co, by calculating ΔGγ→ε, and examining the value, it is possible to specify elements effective for increasing SFE of the Co-based alloy.
As the above results show, in the Co-based alloy for a living body of the present invention, as the alloy elements to be added to the Co—Cr—W-based alloy, alloy elements that exhibit biocompatibility and have an effect of increasing the stacking fault energy of the alloy are preferable. Among these, Fe is added since this element can make a Ni-free Co-based alloy for a living body that has a high degree of strength and elastic modulus and is excellent in the plastic workability. If Fe is added to the Co—Cr—W-based alloy, the tensile strength and Young's modulus of the Co—Cr—W-based alloy can be improved as described later in examples, and a Ni-free Co-based alloy for a living body that has a high degree of strength and elasticity and is excellent in the plastic workability can be obtained. In addition, this alloy contains W, and W is an element heavier than Co, Cr, and Ni. Therefore, overall density of the alloy increases, and even if the alloy is worked into an extremely thin alloy as an alloy for a stent, a high degree of X-ray visibility can be exhibited. Accordingly, the Co-based alloy for a living body of the present invention is suitable as an alloy for a stent.
The Co-based alloy for a living body of the present invention is a Co-based alloy for a living body based on Co—Cr—W—Fe, and has a composition of Cr: 5% by mass to 30% by mass, W: 5% by mass to 20% by mass, Fe: 1% by mass to 15% by mass, Co as the remainder, and unavoidable impurities.
In addition, the Co-based alloy for a living body of the present invention may be a Co-based alloy for a living body based on Co—Cr—W—Fe—C and have a composition of Cr: 5% by mass to 30% by mass, W: 5% by mass to 20% by mass, Fe: 1% by mass to 15% by mass, C: 0.01% by mass to 0.15% by mass, Co as the remainder, and unavoidable impurities. When the alloy contains C, the content of C more preferably ranges from 0.05% by mass to 0.10% by mass.
In the Co-based alloy for a living body based on Co—Cr—W—Fe, when the content of W is 5% by mass to 10% by mass, the content of Fe is preferably 1% by mass to 5% by mass.
In the Co-based alloy for a living body based on Co—Cr—W—Fe, when the content of W is 11% by mass to 20% by mass, the content of Fe is preferably 3% by mass to 15% by mass.
Next, regarding the alloy based on the above elements, the determination results of the precipitation of the TCP-phase obtained by PHACOMP (Phase Computation) will be described based on the calculation formula and the calculation results shown in
PHACOMP refers to a technique of determining precipitation (in an FCC alloy) of the TCP-phase (σ, μ, R, x, Leaves) by using phase calculation applying electron theory, and can be represented by the following Formulae (3) and (4). It is said that in the Co-based alloy, TCP is easily precipitated with Nv≧2.7. Nv represents the Average electron-hole number.
As shown in the determination results of the TCP-phase precipitation shown in
In the examples described later, the alloy composition of examples and the alloy composition of comparative examples were selected based on the above results.
For the Co-based alloy for a living body of the present invention, Fe as an alloy element that exhibits biocompatibility and has an effect of increasing the Stacking Fault Energy (SFE) of a Co—Cr—W-based alloy is added to the Co—Cr—W-based alloy. In this manner, the γ-phase of the alloy is stabilized, and the formation of strain-induced martensite ε-phase in the step of working is prevented, whereby the plastic workability can be improved. In addition, since the Co-based alloy for a living body of the present invention does not contain Ni, there is no concern that the alloy may cause a Ni allergy in the living body.
Moreover, since the Co-based alloy for a living body of the present invention has a composition obtained by adding Fe to the Co—Cr—W-based alloy, not only the plastic workability of the Co-based alloy, but also the elastic modulus and tensile strength can be improved. Furthermore, since the Co-based alloy for a living body contains W, the X-ray visibility of the alloy having the composition of the present invention can be improved, so the alloy is suitable as an alloy for a stent.
The Co-based alloy for a living body of the present invention may be an alloy having a composition of Co—Cr—W—Fe—C.
In the case of the alloy based on the above elements, the composition of Cr, W, and Fe is in the same range as in the alloy based on Co—Cr—W—Fe described above, and C is further contained in the alloy in a range of from 0.01% by mass to 0.15% by mass. The content of C is more preferably 0.05% by mass to 0.10% by mass.
In the alloy based on Co—Cr—W—Fe, when the TCP-phase which is hard and brittle, such as the μ-phase or the σ-phase, is precipitated, there is a concern that the alloy may be cracked during hot casting due to the presence of these brittle precipitates. If the composition of Cr, W, and Fe is specified as being within the above range, and the C is contained in the alloy within the above range, the precipitation of the TCP-phase can be inhibited, whereby the cracking caused during hot casting can be inhibited. Consequently, the plastic workability can be improved.
Next, the stent of the present invention will be described.
The stent of the present invention is used by being inserted into stenosed portions in blood vessels, bile ducts, and the like in the living body so as to dilate the lumens and maintain the luminal diameter, and uses the Co-based alloy for a living body of the present invention.
As a method of preparing the stent 1 having such a structure, for example, a pipe with a length, a diameter, a wall thickness, and the like having desired dimensions is formed using the Co-based alloy for a living body of the present invention, and then the side of the pipe is partially cut out by a cutting process or the like to form a plurality of notch portions 1b, whereby the stent 1 can be prepared.
In
Using the Co-based alloy for a living body of the present invention described above, the stent of the present invention does not cause a Ni allergy and has an excellent elastic modulus and tensile strength. In addition, for the Fe-added Co-based alloy for a living body of the present invention, Fe is selected as an alternative element for Ni, whereby an effect of improving workability (ductility) is obtained.
Hereinafter, the present invention will be described in more detail based on examples, but the present invention is not limited to the examples described below.
Alloys of Examples 1 to 12 and Comparative Examples 1 and 2, and example alloys in the related art that contain the respective elements as the component composition shown in the following Table 2 were prepared in the following manner.
By using a high-frequency vacuum induction melting furnace, the respective elements were mixed in the component composition shown in Table 2 and dissolved, thereby obtaining a molten alloy. The molten alloy was cast into a metallic mold under an Ar atmosphere of 800 Pa, and the furnace was cooled. The ingot was shaped into a cylinder having sizes of a diameter of the upper portion of 80 mm, a diameter of the lower portion of 70 mm, and a height of 120 mm and a mass of 6 kg. Thereafter, in order to prevent solidification segregation, homogenization thermal treatment was performed on the ingot at 1220° C. for 10 hours under an Ar atmosphere by using a high-temperature high-vacuum furnace manufactured by TOKYO VACUUM, Co, Ltd., and then the furnace was cooled to room temperature, thereby preparing the respective alloys. During the homogenization thermal treatment, the rate of temperature increase was set to 10° C./min, and the cooling rate was set to 10° C./min.
From the results shown in
Accordingly, in the Co—Cr—W—Fe-based alloy, it is preferable to calculate the γ-phase stabilization effect produced by the addition of Fe and the γ-phase stabilization effect produced by the addition of W, and to set the amount of each of Fe and W within a suitable range.
Regarding the cold workability, from the results shown in
Comparing
From these views showing the phases of alloys, it is understood that if the content of C is set to be in the above range, the TCP-phase can be reduced, and accordingly, the improvement of plastic workability such as the reduction of cracking in hot casting can be realized.
From these views showing the phases of alloys, it is understood that if the content of C is set to be in the above range, the TCP-phase can be reduced, and accordingly, the improvement of plastic workability such as the reduction of cracking in hot casting can be realized.
Number | Date | Country | Kind |
---|---|---|---|
2012-044546 | Feb 2012 | JP | national |